9 Breast Cancer Clinical Trials in Indianapolis, IN (2026)

Q: How do I join a clinical trial in Indianapolis?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you.

Recruiting Breast Cancer Studies in Indianapolis

NCT06324357Recruiting

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

This study is open to adults aged 18 years and older with different types of HER2+ cancer that has spread and cannot be removed by surgery. People can take part in this study if their tumours show HER...

Indianapolis, INPHASE1768 participantsBoehringer Ingelheim

View Study Details

NCT07287098Recruiting

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

This study will include two groups of patients: Cohort 1 and Cohort 2. Cohort 1: will help researchers learn how a medicine called imlunestrant (LY3484356) affects a specific type of breast cancer. S...

Indianapolis, INPHASE2600 participantsEli Lilly and Company

View Study Details

NCT06134375Recruiting

A Study of Tetrathiomolybdate (TM) Plus Capecitabine

There are two parts to this study. It is a phase 1b followed by a randomized phase 2 study to assess whether adding 3 years of adjuvant tetrathiomolybdate (TM) to standard 6 months treatment of adjuva...

Indianapolis, INPHASE1204 participantsDartmouth-Hitchcock Medical Center

View Study Details

NCT05846789Recruiting

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

This is a randomized Phase II study of standard of care (SOC) chemotherapy monotherapy vs. SOC chemotherapy combined with tocilizumab in in Black and non-Black patients with metastatic triple negative...

Indianapolis, INPHASE2168 participantsKathy Miller

View Study Details

NCT05468034Recruiting

Exercise in Metastatic Breast Cancer: EMBody

The purpose of this study is to study exercise in a novel population with indolent MBC (no progression on current therapy in prior 12 months and not receiving cytotoxic chemotherapy). The study team h...

Indianapolis, INNA100 participantsIndiana University

View Study Details

NCT04841148Recruiting

Avelumab or Hydroxychloroquine with or Without Palbociclib to Eliminate Dormant Breast Cancer

This clinical trial will assess the safety and early efficacy of Hydroxychloroquine or Avelumab, with or without Palbociclib, in early-stage ER+ breast cancer patients who are found to harbor dissemin...

Indianapolis, INPHASE296 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT05557877Recruiting

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) women planning to have a breast biopsy. Chronic inflammation may increase the ris...

Indianapolis, INPHASE260 participantsMayo Clinic

View Study Details

NCT06949410Recruiting

HER2 Vaccine for Locally Advanced Breast Cancer

The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer....

Indianapolis, INPHASE136 participantsPravin T.P Kaumaya

View Study Details

NCT06744465Recruiting

NearWave Optical Molecular Monitoring

The purpose of this study is to assess the feasibility of the NearWave optical molecular monitoring system for monitoring therapy progression and predicting pathologic complete response (pCR) of breas...

Indianapolis, INNA15 participantsIndiana University

View Study Details

About Breast Cancer Clinical Trials in Indianapolis

Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.

There are currently 9 breast cancer clinical trials recruiting participants in Indianapolis, IN. These studies are seeking a combined 2,047 participants. Research is being sponsored by Boehringer Ingelheim, Eli Lilly and Company, Dartmouth-Hitchcock Medical Center and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Breast Cancer Clinical Trials in Indianapolis — FAQ

Are there breast cancer clinical trials in Indianapolis?

Yes, there are 9 breast cancer clinical trials currently recruiting in Indianapolis, IN. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Indianapolis?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Indianapolis research site will contact you about next steps.

Are clinical trials in Indianapolis free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Indianapolis studies also compensate for your time and travel.

What breast cancer treatments are being tested?

The 9 active trials in Indianapolis are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.

Data updated July 17, 2026 from ClinicalTrials.gov